Logo image of MTEX

MANNATECH INC (MTEX) Stock Fundamental Analysis

NASDAQ:MTEX - Nasdaq - US5637712036 - Common Stock - Currency: USD

9  -0.45 (-4.76%)

Fundamental Rating

2

MTEX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 35 industry peers in the Personal Care Products industry. MTEX has a bad profitability rating. Also its financial health evaluation is rather negative. MTEX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MTEX had negative earnings in the past year.
MTEX had a negative operating cash flow in the past year.
In multiple years MTEX reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: MTEX reported negative operating cash flow in multiple years.
MTEX Yearly Net Income VS EBIT VS OCF VS FCFMTEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

1.2 Ratios

The Return On Assets of MTEX (-0.60%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -2.90%, MTEX is in line with its industry, outperforming 54.29% of the companies in the same industry.
Industry RankSector Rank
ROA -0.6%
ROE -2.9%
ROIC N/A
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
MTEX Yearly ROA, ROE, ROICMTEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

In the last couple of years the Profit Margin of MTEX has remained more or less at the same level.
MTEX's Operating Margin has declined in the last couple of years.
The Gross Margin of MTEX (76.58%) is better than 88.57% of its industry peers.
MTEX's Gross Margin has been stable in the last couple of years.
MTEX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.58%
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
MTEX Yearly Profit, Operating, Gross MarginsMTEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

MTEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
MTEX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MTEX has been reduced compared to 5 years ago.
Compared to 1 year ago, MTEX has a worse debt to assets ratio.
MTEX Yearly Shares OutstandingMTEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
MTEX Yearly Total Debt VS Total AssetsMTEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.60 indicates that MTEX is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 3.60, MTEX perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
MTEX has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
MTEX has a Debt to Equity ratio of 0.46. This is in the lower half of the industry: MTEX underperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z 3.6
ROIC/WACCN/A
WACC9.29%
MTEX Yearly LT Debt VS Equity VS FCFMTEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

MTEX has a Current Ratio of 1.18. This is a normal value and indicates that MTEX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.18, MTEX is not doing good in the industry: 65.71% of the companies in the same industry are doing better.
MTEX has a Quick Ratio of 1.18. This is a bad value and indicates that MTEX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of MTEX (0.65) is worse than 74.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.65
MTEX Yearly Current Assets VS Current LiabilitesMTEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.77% over the past year.
Measured over the past years, MTEX shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.73% on average per year.
Looking at the last year, MTEX shows a decrease in Revenue. The Revenue has decreased by -9.62% in the last year.
The Revenue has been decreasing by -5.66% on average over the past years.
EPS 1Y (TTM)87.77%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%-228.5%
Revenue 1Y (TTM)-9.62%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-9.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MTEX Yearly Revenue VS EstimatesMTEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MTEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MTEX Price Earnings VS Forward Price EarningsMTEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MTEX indicates a somewhat cheap valuation: MTEX is cheaper than 65.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.47
MTEX Per share dataMTEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

MTEX has a Yearly Dividend Yield of 8.83%, which is a nice return.
Compared to an average industry Dividend Yield of 5.76, MTEX pays a better dividend. On top of this MTEX pays more dividend than 94.29% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.43, MTEX pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.83%

5.2 History

MTEX has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
MTEX Yearly Dividends per shareMTEX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 0.5 1 1.5 2

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
MTEX Yearly Income VS Free CF VS DividendMTEX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

More info and screens

MANNATECH INC

NASDAQ:MTEX (6/27/2025, 4:15:45 PM)

9

-0.45 (-4.76%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-13 2025-05-13
Earnings (Next)08-11 2025-08-11
Inst Owners18.93%
Inst Owner Change9.76%
Ins Owners44.9%
Ins Owner Change0%
Market Cap17.10M
Analysts0
Price TargetN/A
Short Float %0.61%
Short Ratio2
Dividend
Industry RankSector Rank
Dividend Yield 8.83%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B 2.25
P/tB 2.25
EV/EBITDA 10.47
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS60.55
BVpS3.99
TBVpS3.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE -2.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.58%
FCFM N/A
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
F-Score3
Asset Turnover3.14
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA 2.96
Cap/Depr 51.38%
Cap/Sales 0.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 0.65
Altman-Z 3.6
F-Score3
WACC9.29%
ROIC/WACCN/A
Cap/Depr(3y)43.45%
Cap/Depr(5y)43.17%
Cap/Sales(3y)0.53%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.77%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%-228.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.62%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-9.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y74.29%
EBIT growth 3Y-45.85%
EBIT growth 5Y-25.91%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.07%
FCF growth 3Y-42.1%
FCF growth 5Y-11.9%
OCF growth 1Y46.39%
OCF growth 3Y-40.57%
OCF growth 5Y-14.4%